Blog

Rep. Ocasio-Cortez Throws Shade at the FDA

Read More »

August 17, 2023 No Comments

TPA’s Latest 50 State Analysis Examines Adult and Youth E-Cigarette Use

Read More »

August 3, 2023 No Comments

Congress must rein in pharmacy benefit managers to lower healthcare costs

Read More »

July 17, 2023 No Comments

Op-Ed: FDA barring life-saving chemotherapies from market

Read More »

June 23, 2023 No Comments

Reality Check: Pharmacy Benefit Managers Offer Little Benefit to Americans

Read More »

June 16, 2023 No Comments

TPA Letter to FDA on Monoclonal Antibodies

Read More »

June 6, 2023 No Comments

TPA Letter to FDA on Monoclonal Antibodies

Read More »

June 6, 2023 No Comments

Op-Ed: FDA About to Make Drug Approvals More Difficult

Read More »

April 24, 2023 No Comments

TPA Led Coalition Sends Letter to White House, HHS, and CMS on Surprise Medical Billing

Read More »

April 5, 2023 No Comments

TPA Endorses Drug Price Transparency in Medicaid Act

Read More »

April 4, 2023 No Comments